These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 9820507)

  • 1. Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division.
    Oehen S; Brduscha-Riem K
    J Immunol; 1998 Nov; 161(10):5338-46. PubMed ID: 9820507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte populations in vivo and in vitro.
    Ehl S; Klenerman P; Aichele P; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1997 Dec; 27(12):3404-13. PubMed ID: 9464829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo state of antiviral CTL precursors. Characterization of a cycling cell population containing CTL precursors in immune mice.
    Razvi ES; Welsh RM; McFarland HI
    J Immunol; 1995 Jan; 154(2):620-32. PubMed ID: 7529281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial.
    Cerwenka A; Morgan TM; Dutton RW
    J Immunol; 1999 Nov; 163(10):5535-43. PubMed ID: 10553081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The phenotype and survival of antigen-stimulated transgenic CD4 T cells in vivo: the influence of persisting antigen.
    Yang CP; Sparshott SM; Duffy D; Garside P; Bell EB
    Int Immunol; 2006 Apr; 18(4):515-23. PubMed ID: 16481344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic characteristics associated with the acquisition of HSV-specific CD8 T-lymphocyte-mediated cytolytic function in vitro.
    McNally JM; Andersen HA; Chervenak R; Jennings SR
    Cell Immunol; 1999 May; 194(1):103-11. PubMed ID: 10357886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells.
    Inaba M; Kurasawa K; Mamura M; Kumano K; Saito Y; Iwamoto I
    J Immunol; 1999 Aug; 163(3):1315-20. PubMed ID: 10415029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
    Riquelme E; Carreño LJ; González PA; Kalergis AM
    Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of adhesion molecule expression by CD8 T cells in vivo. II. Expression of L-selectin (CD62L) by memory cytolytic T cells responding to minor histocompatibility antigens.
    Mobley JL; Rigby SM; Dailey MO
    J Immunol; 1994 Dec; 153(12):5443-52. PubMed ID: 7527441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics and requirements of T cell clonal expansion in vivo at the single-cell level: effector function is linked to proliferative capacity.
    Gudmundsdottir H; Wells AD; Turka LA
    J Immunol; 1999 May; 162(9):5212-23. PubMed ID: 10227995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic identification of antigen-dependent and antigen-independent CD8 CTL precursors in the draining lymph node during acute cutaneous herpes simplex virus type 1 infection.
    McNally JM; Dempsey D; Wolcott RM; Chervenak R; Jennings SR
    J Immunol; 1999 Jul; 163(2):675-81. PubMed ID: 10395657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar ligand densities required for restimulation and effector function of cytotoxic T cells.
    Oxenius A; Bachmann MF
    Cell Immunol; 1997 Jul; 179(1):16-21. PubMed ID: 9259767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus-induced polyclonal B cell activation improves protective CTL memory via retained CD27 expression on memory CTL.
    Matter M; Mumprecht S; Pinschewer DD; Pavelic V; Yagita H; Krautwald S; Borst J; Ochsenbein AF
    Eur J Immunol; 2005 Nov; 35(11):3229-39. PubMed ID: 16231287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirements for CD28-dependent T cell-mediated cytotoxicity.
    Azuma M; Cayabyab M; Phillips JH; Lanier LL
    J Immunol; 1993 Mar; 150(6):2091-101. PubMed ID: 8383716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective immunity from naive CD8+ T cells activated in vitro with MHC class I binding immunogenic peptides and IL-2 in the absence of specialized APCs.
    Hauser C; Zipprich F; Leblond I; Wirth S; Hügin AW
    J Immunol; 1999 Jul; 163(1):330-6. PubMed ID: 10384132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualizing memory phenotype development after in vitro stimulation of CD4(+) T cells.
    Lee WT; Pelletier WJ
    Cell Immunol; 1998 Aug; 188(1):1-11. PubMed ID: 9743552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor regression after adoptive transfer of effector T cells is independent of perforin or Fas ligand (APO-1L/CD95L).
    Winter H; Hu HM; Urba WJ; Fox BA
    J Immunol; 1999 Oct; 163(8):4462-72. PubMed ID: 10510388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of central memory CD8 T cells is independent of CD62L-mediated trafficking to lymph nodes.
    Wirth TC; Badovinac VP; Zhao L; Dailey MO; Harty JT
    J Immunol; 2009 May; 182(10):6195-206. PubMed ID: 19414773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of IL-2-dependent cytolytic T lymphocytes (CTLs) with altered TCR responses derived from antigen-dependent CTL clones.
    Gullo CA; Esser MT; Fuller CL; Lam Braciale V
    J Immunol; 1999 Jun; 162(11):6466-72. PubMed ID: 10352261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice.
    Distler E; Wölfel C; Köhler S; Nonn M; Kaus N; Schnürer E; Meyer RG; Wehler TC; Huber C; Wölfel T; Hartwig UF; Herr W
    Exp Hematol; 2008 Apr; 36(4):451-63. PubMed ID: 18261837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.